Matches in Wikidata for { <http://www.wikidata.org/entity/Q88188520> ?p ?o ?g. }
- Q88188520 description "2018 nî lūn-bûn" @default.
- Q88188520 description "2018年の論文" @default.
- Q88188520 description "2018年学术文章" @default.
- Q88188520 description "2018年学术文章" @default.
- Q88188520 description "2018年学术文章" @default.
- Q88188520 description "2018年学术文章" @default.
- Q88188520 description "2018年学术文章" @default.
- Q88188520 description "2018年学术文章" @default.
- Q88188520 description "2018年學術文章" @default.
- Q88188520 description "2018年學術文章" @default.
- Q88188520 description "2018年學術文章" @default.
- Q88188520 description "2018年學術文章" @default.
- Q88188520 description "2018年學術文章" @default.
- Q88188520 description "2018년 논문" @default.
- Q88188520 description "article científic" @default.
- Q88188520 description "article scientific" @default.
- Q88188520 description "article scientifique" @default.
- Q88188520 description "articol științific" @default.
- Q88188520 description "articolo scientifico" @default.
- Q88188520 description "artigo científico" @default.
- Q88188520 description "artigo científico" @default.
- Q88188520 description "artigo científico" @default.
- Q88188520 description "artikel ilmiah" @default.
- Q88188520 description "artikull shkencor" @default.
- Q88188520 description "artikulong pang-agham" @default.
- Q88188520 description "artykuł naukowy" @default.
- Q88188520 description "artículo científico publicado en 2018" @default.
- Q88188520 description "artículu científicu" @default.
- Q88188520 description "bilimsel makale" @default.
- Q88188520 description "bài báo khoa học" @default.
- Q88188520 description "naučni članak" @default.
- Q88188520 description "scienca artikolo" @default.
- Q88188520 description "scientific article published on 27 March 2018" @default.
- Q88188520 description "scientific article published on 27 March 2018" @default.
- Q88188520 description "scientific article published on 27 March 2018" @default.
- Q88188520 description "teaduslik artikkel" @default.
- Q88188520 description "tieteellinen artikkeli" @default.
- Q88188520 description "tudományos cikk" @default.
- Q88188520 description "vedecký článok" @default.
- Q88188520 description "vetenskaplig artikel" @default.
- Q88188520 description "videnskabelig artikel udgivet 27. marts 2018" @default.
- Q88188520 description "vitenskapelig artikkel" @default.
- Q88188520 description "vitskapeleg artikkel" @default.
- Q88188520 description "vědecký článek" @default.
- Q88188520 description "wetenschappelijk artikel" @default.
- Q88188520 description "wissenschaftlicher Artikel" @default.
- Q88188520 description "επιστημονικό άρθρο" @default.
- Q88188520 description "мақолаи илмӣ" @default.
- Q88188520 description "наукова стаття, опублікована в березні 2018" @default.
- Q88188520 description "научна статия" @default.
- Q88188520 description "научная статья" @default.
- Q88188520 description "научни чланак" @default.
- Q88188520 description "научни чланак" @default.
- Q88188520 description "գիտական հոդված հրատարակված 2018 թվականի մարտի 27-ին" @default.
- Q88188520 description "מאמר מדעי" @default.
- Q88188520 description "مقالة علمية نشرت في 27 مارس 2018" @default.
- Q88188520 description "২৭ মার্চ ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q88188520 description "บทความทางวิทยาศาสตร์" @default.
- Q88188520 description "სამეცნიერო სტატია" @default.
- Q88188520 name "Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study" @default.
- Q88188520 name "Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study" @default.
- Q88188520 type Item @default.
- Q88188520 label "Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study" @default.
- Q88188520 label "Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study" @default.
- Q88188520 prefLabel "Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study" @default.
- Q88188520 prefLabel "Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study" @default.
- Q88188520 P1433 Q88188520-23416F7D-8F1E-42BB-A427-2FBA1EC9C802 @default.
- Q88188520 P1476 Q88188520-0B67A48D-F73E-480B-9064-C6405BE7DF6E @default.
- Q88188520 P2093 Q88188520-01F56883-F584-4CE3-A04C-E0CDC8ADD25F @default.
- Q88188520 P2093 Q88188520-02A39FC4-E455-424A-9901-B2A47DB4AA0E @default.
- Q88188520 P2093 Q88188520-11649882-A06B-4572-9A9A-70A26F645B15 @default.
- Q88188520 P2093 Q88188520-49ED213A-95C7-4F0F-B579-A70AA9B96DF6 @default.
- Q88188520 P2093 Q88188520-606603BA-0259-41D4-AA3E-027A90B7C3D3 @default.
- Q88188520 P2093 Q88188520-83D7BB37-9237-41B0-8943-25724E708F39 @default.
- Q88188520 P2093 Q88188520-A968775C-185A-4E85-B812-BAFED19B8C29 @default.
- Q88188520 P2093 Q88188520-B7022337-470C-4E0D-9CDF-5FF0123F017A @default.
- Q88188520 P2093 Q88188520-C6406A4A-A1D4-459B-857A-F18206BF028F @default.
- Q88188520 P2093 Q88188520-CDEC032C-75C5-4F61-A305-E6FDF4093910 @default.
- Q88188520 P2093 Q88188520-D15D7684-627B-473D-8A9A-F6A1D96A439A @default.
- Q88188520 P2093 Q88188520-E29C4E0E-D9D2-4CE4-B0C3-DED5CFD3D744 @default.
- Q88188520 P304 Q88188520-6DB4E021-7730-4BB9-84FE-E7670FE71808 @default.
- Q88188520 P31 Q88188520-E6ABC210-A5CF-47ED-9065-E56947A13490 @default.
- Q88188520 P356 Q88188520-0122A38A-06E2-4DAC-A2EA-09687835F997 @default.
- Q88188520 P433 Q88188520-FFC41E21-7E2B-4442-8FB6-DD16B8DC2150 @default.
- Q88188520 P478 Q88188520-950D7C7D-DBD7-4DFC-8EC8-AF8A43FAD9B2 @default.
- Q88188520 P50 Q88188520-4A90436C-4ADC-4017-AA77-467C5F543AD4 @default.
- Q88188520 P50 Q88188520-91448DEB-5E5C-4EA6-BA1C-AD49E8387694 @default.
- Q88188520 P50 Q88188520-BAF54117-3FAF-4E55-85AF-39DB9CEC9EA5 @default.
- Q88188520 P50 Q88188520-D1D7C2CD-FE3B-45D7-952F-EE4F241E692A @default.
- Q88188520 P50 Q88188520-DBD6D523-1890-47DE-82EC-C1EACE9F803F @default.
- Q88188520 P577 Q88188520-FFD4DDCD-B0B4-46C6-B354-3280DE13441D @default.
- Q88188520 P698 Q88188520-F64A6AC1-9086-4C11-94A3-9B32DD75DE19 @default.
- Q88188520 P921 Q88188520-4A482C9A-DC75-4A78-A586-01E4C886B91E @default.
- Q88188520 P921 Q88188520-59057E7D-3FCD-4EC2-916A-C178089F9C9D @default.
- Q88188520 P356 JCO.2017.76.3656 @default.
- Q88188520 P698 29584548 @default.
- Q88188520 P1433 Q400292 @default.
- Q88188520 P1476 "Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study" @default.
- Q88188520 P2093 "Andrea Knapp" @default.
- Q88188520 P2093 "Anne Lennard" @default.